Current Trends and Glimpse for All Pharma Global Regulatory Agencies Requirements of Nitrosamine and NDSRIs Impurities in Pharmaceuticals
Journal Title: Der Pharma Chemica - Year 2024, Vol 16, Issue 2
Abstract
The USFDA and EMEA announced in July 2018 that N-Nitroso Dimethylamine and N-N-NDMA are concentrated on pharmaceutical medicinal products and specifically used in case of SARTANS that are used in the treatment of hypertension and angiotensin II receptor blockers, bringing the seriousness of nitrosamine presence to light. Subsequently, the diabetes medication pioglitazone and the histamine-2 blocker ranitidine were added to the list. Nitrosamines are created when amines, secondary amide carbamates and urea derivatives react with nitrates and nitrogenous agents. Nitrogen is at an oxidation state of +3. Pharmaceutical product degradation, catalysts, solvents, chemical reagents, cross-contamination, the manufacturing process and raw material contamination are some of the causes of nitrosamine presence in pharmaceutical products. Nitrosamine Impurity is detected using technologies such as gas chromatography, mass spectroscopy and light chromatography mass spectroscopy. According to ICH recommendations, N-nitrosamines are classified as a "cohort of concern" because they may be carcinogen and mutagen. The natural world. Class 2A human substances include N-nitroso dimethylamine and N-nitroso diethylamine. The possibility of N-nitrosamine contaminants in pharmaceutical goods poses a problem for the control of medical product quality. N-nitrosamines are regarded as substances of concern since many of the structurally straightforward molecules in this class have strong carcinogenic properties.
Authors and Affiliations
Rashid Azeez, Kalyani Bhor and Vinod A Bairagi
Keywords
Related Articles
- EP ID EP742508
- DOI 10.4172/0975- 413X.16.2.263-273
- Views 73
- Downloads 0
Analytical Method Development for Dorzolamide Using UV Spectroscopy
The development and evaluation of an analytical technique for the UV spectroscopy based determination of Dorzolamide is the main focus of this study. Dorzolamide, a carbonic anhydrase inhibitor, is utilized to reduce int...
Microsponge: An Innovative and Novel Strategy for Drug Delivery System
The microsponge approach has become a highly competitive and rapidly evolving technology. They are porous, highly cross-linked, polymeric microspheres that can be efficiently incorporated into topical drug delivery syste...
β Sitosterol Quantification Using HPTLC in the Crude Seed Extracts for Potential Male Contraception Activity
β sitosterol is one of the main subcomponents of a group of plant sterols known as phytosterols that are very similar in composition to cholesterol. It is found to be present in many plant tissues like the leaves, roots,...
Exploring the Potential Flavonoids as an Anti-Rheumatoid Arthritis Agent: An In silico Studies
Rheumatoid arthritis is an autoimmune disease which causes systemic complications, disability and even death. Its pathophysiology involves chronic inflammation of synovial membrane. New molecules in the biologic pathway...
Current Trends and Glimpse for All Pharma Global Regulatory Agencies Requirements of Nitrosamine and NDSRIs Impurities in Pharmaceuticals
The USFDA and EMEA announced in July 2018 that N-Nitroso Dimethylamine and N-N-NDMA are concentrated on pharmaceutical medicinal products and specifically used in case of SARTANS that are used in the treatment of hyperte...